Safety Alerts Saves Lives
Safety Alerts  
Home Privacy About Us Contact Us Change Preferences
" "
Safety Alerts
July 27, 1999

Solvay Pharmaceuticals Recalls Rowasa Rectal Suppositories

Marietta, GA (SafetyAlerts) - The Food and Drug Administration (FDA) today reported that Solvay Pharmaceuticals is recalling Rowasa Rectal Suppositories because of dissolution failure and/or lack of assurance of stability through labeled expiry date.

Rowasa Rectal Suppositories (Mesalamine, 500 mg), in cartons of 12, 24, and physician sample of 2's, Rx indicated for the treatment of active ulcerative proctitis.

Recall #D-282-9.

All lot numbers remaining within expiration date.

G&W Laboratories, Plainfield, New Jersey (contract manufacturer).

Solvay Pharmaceuticals, Marietta, Georgia, by letter mailed on May 18, 1999, and by voice mail on May 11, 1999. Firm-initiated recall ongoing.

Nationwide and Puerto Rico.

307,137 cartons of 12; 254,946 cartons of 24;and 100,281 pyhysician samples were distributed.


The information contained herein has been obtained from sources that the Company believes to be reliable, however, the Company has not independently verified or confirmed the information and the recipient acknowledges that no representations or warranties are being made in connection with the use of the information.